Sale!

GRIN2A Gene Epilepsy with neurodevelopmental defects Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “GRIN2A Gene Epilepsy with Neurodevelopmental Defects Genetic Test” is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the GRIN2A gene, which have been linked to various forms of epilepsy accompanied by neurodevelopmental defects. This test is particularly crucial for individuals who exhibit symptoms of epilepsy along with cognitive, behavioral, or motor development issues, as it can provide a definitive genetic diagnosis. The GRIN2A gene plays a significant role in the functioning of NMDA receptors, which are vital for synaptic transmission and plasticity in the brain, influencing learning and memory. Mutations in this gene can disrupt these processes, leading to the aforementioned conditions.

The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any abnormalities in the GRIN2A gene. The results can offer valuable insights into the specific type of epilepsy and neurodevelopmental disorder the individual might have, guiding treatment decisions and management strategies. It can also provide information on the risk of passing the condition to future offspring, which is crucial for family planning.

The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the GRIN2A gene. While the price might seem high, the potential benefits of obtaining a precise diagnosis and the consequent tailored treatment plan can be invaluable for affected individuals and their families. DNA Labs UAE is equipped with state-of-the-art facilities and employs experts in genetic testing, ensuring high-quality services and reliable results.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GRIN2A Gene Epilepsy with neurodevelopmental defects Genetic Test

Test Name: GRIN2A Gene Epilepsy with neurodevelopmental defects Genetic Test

Components: NGS (Next-Generation Sequencing) Technology

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for GRIN2A Gene Epilepsy with neurodevelopmental defects NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GRIN2A Gene Epilepsy with neurodevelopmental defects.

Test Details

The GRIN2A gene is associated with a form of epilepsy known as epilepsy with neurodevelopmental defects. This condition is characterized by seizures that typically begin in early childhood and are often accompanied by developmental delays, intellectual disability, and other neurological symptoms.

NGS (next-generation sequencing) genetic testing is a method of analyzing DNA that can detect mutations or variations in multiple genes simultaneously. This type of testing can be useful in diagnosing genetic conditions, including epilepsy with neurodevelopmental defects caused by mutations in the GRIN2A gene.

NGS genetic testing involves sequencing the entire coding region of the GRIN2A gene, as well as other genes associated with epilepsy and neurodevelopmental disorders. The results of this testing can help healthcare providers determine the cause of a patient’s symptoms and develop a personalized treatment plan.

It is important to note that genetic testing may not be necessary for all individuals with epilepsy and neurodevelopmental defects, and that a thorough clinical evaluation and other diagnostic tests may also be necessary. Additionally, genetic testing can have limitations, including the possibility of false positives or false negatives. It is important to discuss the potential risks and benefits of genetic testing with a healthcare provider before undergoing testing.

Test Name GRIN2A Gene Epilepsy with neurodevelopmental defects Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GRIN2A Gene Epilepsy with neurodevelopmental defects NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GRIN2A Gene Epilepsy with neurodevelopmental defects
Test Details

The GRIN2A gene is associated with a form of epilepsy known as epilepsy with neurodevelopmental defects. This condition is characterized by seizures that typically begin in early childhood and are often accompanied by developmental delays, intellectual disability, and other neurological symptoms.

NGS (next-generation sequencing) genetic testing is a method of analyzing DNA that can detect mutations or variations in multiple genes simultaneously. This type of testing can be useful in diagnosing genetic conditions, including epilepsy with neurodevelopmental defects caused by mutations in the GRIN2A gene.

NGS genetic testing involves sequencing the entire coding region of the GRIN2A gene, as well as other genes associated with epilepsy and neurodevelopmental disorders. The results of this testing can help healthcare providers determine the cause of a patient’s symptoms and develop a personalized treatment plan.

It is important to note that genetic testing may not be necessary for all individuals with epilepsy and neurodevelopmental defects, and that a thorough clinical evaluation and other diagnostic tests may also be necessary. Additionally, genetic testing can have limitations, including the possibility of false positives or false negatives. It is important to discuss the potential risks and benefits of genetic testing with a healthcare provider before undergoing testing.